Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Oncology Research|November 8, 2001
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivityM Coronnello, G Marcon, S Carotti, et al.Neuroscience Letters|May 8, 1998
Implication of alpha1-antichymotrypsin polymorphism in familial Alzheimer's diseaseB Nacmias, G Marcon, A Tedde, et al.Molecular Medicine (Cambridge, Mass.)|December 29, 2000
Presenilin 2 mutation does not influence expression and concentration of APP forms in human plateletsL Pastorino, F Colciaghi, G Marcon, et al.Giornale Di Clinica Medica|April 1, 1989
[Liver cirrhosis. Survival of a homogeneous population]G Donà, L Rocco, M Scevola, et al.Neuromuscular Disorders : NMD|July 10, 1999
Congenital hypomyelination neuropathy with Ser72Leu substitution in PMP22A Simonati, G M Fabrizi, A Pasquinelli, et al.The American Journal of Pathology|May 11, 1999
A betaPP peptide carboxyl-terminal to Abeta is neurotoxicG Marcon, G Giaccone, B Canciani, et al.Journal of Medicinal Chemistry|September 23, 2000
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compoundsL Messori, F Abbate, G Marcon, et al.Infection and Immunity|June 24, 2005
Protective properties of rifampin-resistant rough mutants of Brucella melitensisR Adone, F Ciuchini, C Marianelli, et al.Biological Psychiatry|September 22, 2001
Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's diseaseB Nacmias, A Tedde, P Forleo, et al.Acta Psychiatrica Scandinavica|December 5, 2019
Who attempts suicide among medical students?G Marcon, G Massaro Carneiro Monteiro, P Ballester, et al.Pageof 4